Elsayed MOK. Treatment of recurrent hepatocellular carcinoma: The current standards and future perspectives. World J Gastrointest Oncol 2025; 17(11): 110735 [PMID: 41281491 DOI: 10.4251/wjgo.v17.i11.110735]
Hanan R. H. Mohamed, Sara A. Diab, Jana W. Mofadal, Yasmine W. Hamdy, Bassema E. Elnewihy, Bassant Haitham, Basma M. I. El-Sherif, Ayman Diab, Gehan Safwat. MTA-NPs induce preferential cytotoxicity, oxidative DNA damage, and mitochondrial apoptosis in human Hep-G2 hepatocellular carcinoma cells. Naunyn-Schmiedeberg's Archives of Pharmacology 2026; doi: 10.1007/s00210-026-05581-6